Matrix metalloproteinase proteomics: substrates, targets, and therapy
- 31 October 2009
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Cell Biology
- Vol. 21 (5), 645-653
- https://doi.org/10.1016/j.ceb.2009.06.006
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaNature Genetics, 2009
- Single proteins might have dual but related functions in intracellular and extracellular microenvironmentsNature Reviews Molecular Cell Biology, 2009
- Synthetic active site-directed inhibitors of metzincins: Achievement and perspectivesMolecular Aspects of Medicine, 2008
- Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite InhibitionOnline Journal of Public Health Informatics, 2008
- The selective MMP‐12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smokeBritish Journal of Pharmacology, 2008
- MMPs as therapeutic targets—Still a viable option?Seminars in Cell & Developmental Biology, 2008
- Triple-Helical Transition State Analogues: A New Class of Selective Matrix Metalloproteinase InhibitorsJournal of the American Chemical Society, 2007
- Inhibition of MMP-2 gelatinolysis by targeting exodomain–substrate interactionsBiochemical Journal, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006